Inspiring Future, Grand Challenge

Search
Close
Search
 
  • home
  • 교수소개
  • 전임교수

교수소개

전임교수

  • 교수 정밀맞춤형헬스
  • 최윤라

학력

  • 1996 의학학사, 서울대학교 의과대학
  • 2002 의학박사, 서울대학교 의과대학

약력/경력

  • 2007-2008 Postdoc, Stanford University
  • 2008~ 성균관대학교 의과대학 교수

학술지 논문

  • (2026)  GraphTME: graph-based framework for predicting immunotherapy response by interpreting tumour microenvironment interactions using spatial transcriptomics.  NPJ SYSTEMS BIOLOGY AND APPLICATIONS. 
  • (2026)  Vitrification-based tissue-to-organoid cryopreservation workflow for colorectal cancer.  NEW BIOTECHNOLOGY.  93, 
  • (2026)  FusionTarget: Computational framework for drug repurposing against modeled fusion protein structures from genomic breakpoints.  ISCIENCE.  29,  6
  • (2026)  Clinical and Molecular Characterization of a Rare EGFR cis Compound L833V/H835L Mutation in Non-Small Cell Lung Cancer.  Cancer Research Communications.  6,  4
  • (2026)  MuCoSA: Multi-contextual similarity assessment for histopathology image search.  Journal of Pathology Informatics.  20, 
  • (2026)  SHEST: single-cell-level artificial intelligence from haematoxylin and eosin morphology for cell-type prediction and spatial transcriptomics reconstruction.  BRIEFINGS IN BIOINFORMATICS.  27,  1
  • (2026)  The role of APOBEC in early-stage epidermal growth factor receptor-mutant non-small cell lung cancer.  LUNG CANCER. 
  • (2025)  Deep Learning Predicts EGFR Mutation Status from Histology Images in Non-Small Cell Lung Cancer.  Cancer Research Communications.  5,  12
  • (2025)  Linking p53 immunostaining to TP53 mutation status in patients with non-small cell lung cancer.  PATHOLOGY.  57,  7
  • (2025)  Perioperative Pembrolizumab for Locally Advanced Thymic Epithelial Tumors: A Single-Arm, Phase 2 Trial.  JOURNAL OF THORACIC ONCOLOGY.  20,  12
  • (2025)  Whole-genome landscapes of 1,364 breast cancers.  NATURE.  649,  8099
  • (2025)  Artificial intelligence-powered spatial analysis of tumor microenvironment in patients with non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitor.  JOURNAL FOR IMMUNOTHERAPY OF CANCER.  13,  10
  • (2025)  Evidential deep learning-based ALK-expression screening using H&E-stained histopathological images.  NPJ DIGITAL MEDICINE.  8,  1
  • (2025)  MET Alterations in Cancer and MET-Targeted Therapy: Detection Strategies, Treatment Efficacy, and Emerging Technologies.  TARGETED ONCOLOGY.  20,  5
  • (2025)  Adjuvant pembrolizumab therapy for completely resected stage I lung adenocarcinoma with micropapillary or solid histological subtypes: a single-center, single-arm, phase 2 trial.  ECLINICALMEDICINE.  84, 
  • (2025)  Palbociclib plus endocrine therapy versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (Young-PEARL): overall survival analysis of a randomised, open-label, phase 2 study.  LANCET ONCOLOGY.  26,  3
  • (2025)  Indirect targeting of MYC and direct targeting in combination with chemotherapies are more effective than direct mono-targeting in triple negative breast cancer.  TRANSLATIONAL ONCOLOGY.  51, 
  • (2025)  The Growth of Screening-Detected Pure Ground-Glass Nodules Following 10 Years of Stability.  CHEST.  167,  4
  • (2024)  Clinical and radiologic features of soft tissue sarcoma in trunk and extremities that underwent unplanned excision.  PLOS ONE.  19,  12 December
  • (2024)  Clinical utility of circulating tumor DNA profiling in detecting targetable fusions in non-small cell lung cancer.  FRONTIERS IN ONCOLOGY.  14, 

학술회의논문

  • (2011)  Comparision of peptide nucleic acid(PNA)-mediated PCR clamping, COLD-PCR, and direct sequencing in detection of PIK3CA, BRAF and KRAS mutations in colorectal cancers.  Association of Molecular Pathology.  미국
  • (2011)  IDH1 mutation is a favorable prognostic factor for type 2 gliomatosis recebri.  Association of Molecular Pathology.  미국
  • (2011)  Testing Practices for EGFR and KRAS in Advanced Non-Small Cell Lung Cancer in a Comprehensive Cancer Care Setting in Korea.  European Society for Medical Oncology.  스웨덴
  • (2011)  Detection of MDM2 and CDK4 by Fluorescence in Situ Hybridization, Immunohistochemistry and Real-time PCR in Liposarcoma: Prognositic Significance based on the Molecular Diagnosis.  USCAP.  미국